Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Müller

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Mutation Research|February 13, 2007
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM WorkshopDavid Kirkland, Stefan Pfuhler, David Tweats, et al.
Nucleic Acids Research|August 30, 2025
Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeysRavi Jagasia, Charlotte Bon, Soren V Rasmussen, et al.
Journal of Medicinal Chemistry|December 13, 2023
Discovery of Orally Available and Brain Penetrant AEP InhibitorsDaniela Krummenacher, Weiping He, Bernd Kuhn, et al.
Haematologica|November 9, 2023
Autologous-allogeneic <i>versus</i> autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients under 60 years of age: a prospective, phase II studyNicolaus Kröger, Gerald Wulf, Ute Hegenbart, et al.
Regulatory Toxicology and Pharmacology : RTP|January 18, 2006
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicityLutz Müller, Robert J Mauthe, Christopher M Riley, et al.
Bone Marrow Transplantation|May 6, 2018
Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working PartiesPeter Dreger, Mauricette Michallet, Paul Bosman, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Mutation Research|February 13, 2007
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM WorkshopDavid Kirkland, Stefan Pfuhler, David Tweats, et al.
Nucleic Acids Research|August 30, 2025
Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeysRavi Jagasia, Charlotte Bon, Soren V Rasmussen, et al.
Journal of Medicinal Chemistry|December 13, 2023
Discovery of Orally Available and Brain Penetrant AEP InhibitorsDaniela Krummenacher, Weiping He, Bernd Kuhn, et al.
Haematologica|November 9, 2023
Autologous-allogeneic <i>versus</i> autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients under 60 years of age: a prospective, phase II studyNicolaus Kröger, Gerald Wulf, Ute Hegenbart, et al.
Regulatory Toxicology and Pharmacology : RTP|January 18, 2006
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicityLutz Müller, Robert J Mauthe, Christopher M Riley, et al.
Bone Marrow Transplantation|May 6, 2018
Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working PartiesPeter Dreger, Mauricette Michallet, Paul Bosman, et al.
Pageof 7